Editor | Curator

Advertisment

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target. REPORT

Incredible Ibogaine Psychedelic’s Testimonial.

TIME MAGAZINE: Marcus Capone, Inside Ibogaine, One of the Most Promising and Perilous Psychedelics for Addiction Scroll down...

America’s Top Doc Bankole Johnson Joins Ehave’s (EHVVF) Medical Advisory Board.

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole...

Psychedelic IPOs Build Momentum (PitchBook).

Psychedelic IPOs build momentum as Atai Life Sciences goes public PITCHBOOK Making its Wall Street debut, Peter Thiel-backed Atai Life Sciences has become the third biotech...

Psychedelic Investor Conferences.

Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 – But Worth Considering! Cowen Psychedelics & Novel Mechanisms...

Biomind Labs Inc. Completes Reverse Take-Over Transaction

TORONTO--(BUSINESS WIRE)--Biomind Labs Inc. (formerly Crosswinds Holdings Inc.) (the “Company”), announces that it has completed its previously announced acquisition of all of the outstanding shares of BioMind Research Corp (“Biomind”),...

10 Psychedelic Startups Investors are Flocking To (Insider Monkey)

In this article, we discuss the 10 psychedelic startups investors are flocking to. If you want to skip our detailed analysis of these startups, go directly to the 5 Psychedelic Startups...

Revive Therapeutics (RVV:CN, RVVTF) Approved to Trade on the OTCQB Market.

TORONTO, June 25, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF, FRANKFURT: 31R), a specialty life sciences company focused on the research and development of...

Editor | Curator

Advertisment